Literature DB >> 2447930

Production of beta-human chorionic gonadotropin by prostatic adenocarcinoma and transitional cell carcinoma of the upper urinary tract.

V M Shah1, J Newman, J Crocker, G N Antonakopoulos, C R Chapple, M J Collard.   

Abstract

Ectopic production and secretion of hormones by a wide variety of tumours has been known for many years. Recently human chorionic gonadotropin (HCG) production and/or secretion have been noted in 15 cases with prostatic adenocarcinoma (Fukutani et al. 1983; Papapetrou et al. 1980: Broder et al. 1977; Menon & Stefani 1980; McManus et al. 1976) and in two with upper urinary tract transitional cell carcinoma (Fukutani et al. 1983; McManus et al. 1976). In this study we utilised the indirect immunoperoxidate technique to demonstrate beta-HCG production in prostatic adenocarcinoma and upper urinary tract urothelial tumours. Of 100 cases of prostatic adenocarcinoma beta-HCG production was demonstrated in nine cases, eight of which were poorly differentiated, and of 14 urothelial tumours of the upper urinary tract beta-HCG production was present in two high grade transitional cell carcinomas.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2447930      PMCID: PMC2013093     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  6 in total

1.  Carcinomas with trophoblastic differentiation and secretion of chorionic gonadotrophins.

Authors:  F Civantos; A M Rywlin
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

2.  The value of biologic markers in diagnosis and treatment of testicular cancer.

Authors:  N Javadpour
Journal:  Semin Oncol       Date:  1979-03       Impact factor: 4.929

3.  Ectopic production of human chorionic gonadotropin (hCG) by neoplasms: the value of measurements of immunoreactive hCG in the urine as a screening procedure.

Authors:  P D Papapetrou; N P Sakarelou; H Braouzi; P Fessas
Journal:  Cancer       Date:  1980-05-15       Impact factor: 6.860

4.  Human chorionic gonadotropin detected in urinary concentrates from patients with malignant tumors of the testis, prostate, bladder, ureter and kidney.

Authors:  K Fukutani; J M Libby; W B Panko; P T Scardino
Journal:  J Urol       Date:  1983-01       Impact factor: 7.450

5.  Ectopic beta-human chorionic gonadotropin production by bladder urothelial neoplasia.

Authors:  V M Shah; J Newman; J Crocker; C R Chapple; M J Collard; J M O'Brien; J Considine
Journal:  Arch Pathol Lab Med       Date:  1986-02       Impact factor: 5.534

6.  Evaluation of human chorionic gonadotropin-beta levels in prostatic carcinoma.

Authors:  M Menon; S S Stefani
Journal:  Urol Int       Date:  1980       Impact factor: 2.089

  6 in total
  6 in total

1.  beta hCG as a prognostic marker in adenocarcinoma of the prostate.

Authors:  M T Sheaff; J E Martin; D F Badenoch; S I Baithun
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

2.  [Urothelium cancer with trophoblastic differentiation. An unusual case of a 77 year old patient].

Authors:  X Krah; E Klose; G Atanassov; G Eschholz; H Kosmehl; H M Weber
Journal:  Urologe A       Date:  2006-01       Impact factor: 0.639

3.  Human chorionic gonadotropin measurements in parathyroid carcinoma.

Authors:  Mishaela R Rubin; John P Bilezikian; Steven Birken; Shonni J Silverberg
Journal:  Eur J Endocrinol       Date:  2008-07-14       Impact factor: 6.664

4.  The expression of beta human chorionic gonadotrophin (β-HCG) in human urothelial carcinoma.

Authors:  Anthony Kodzo-Grey Venyo; David Herring; Harold Greenwood; Douglas John Lindsay Maloney
Journal:  Pan Afr Med J       Date:  2010-12-16

Review 5.  Clinical significance of serum biomarkers in pediatric solid mediastinal and abdominal tumors.

Authors:  John A Sandoval; Linda H Malkas; Robert J Hickey
Journal:  Int J Mol Sci       Date:  2012-01-20       Impact factor: 6.208

6.  Multiple endocrine disorders manifested as gynecomastia in a patient with renal pelvis cancer.

Authors:  Vladimir Bilim; Senji Hoshi
Journal:  Clin Case Rep       Date:  2022-02-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.